Treatment of rheumatoid arthritis patients – a challenge

Treatment of rheumatoid arthritis patients – a challenge

Rheumatoid arthritis (RA) is a chronic, systemic inflammatory autoimmune disease with unclear etiology that involves the peripheral joints symmetrically, causing synovial hypertrophy, inflammation and, consequently, erosions of the bone and cartilage. We hereby present the case of a 51-year-old fema...

Full description

Bibliographic Details
Main Authors:	Luiza Maria Pana, Daniel Nicolae Costea, Razvan Adrian Ionescu
Format:	Article
Language:	English
Published:	Amaltea Medical Publishing House 2020-09-01
Series:	Romanian Journal of Rheumatology
Subjects:	rheumatoid arthritis anti-tumor necrosis alpha anti tnf alpha infliximab monoclonal antibodies peritoneal tuberculosis
Online Access:	https://rjr.com.ro/articles/2020.3/RJR_2020_3_Art-06.pdf

Similar Items

Development of Anti-bodies against Infliximab in Iraqi Patients with Rheumatoid Arthritis.
by: Mohammed A. Al-Karkhi, et al.
Published: (2015-10-01)

Effect of TNF-α Blockade in Gingival Crevicular Fluid on Periodontal Condition of Patients with Rheumatoid Arthritis
by: Zeinab Kadkhoda, et al.
Published: (2016-09-01)

Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events
by: Subedi S, et al.
Published: (2019-07-01)

Latent Tuberculosis Infection and Tuberculosis Development in Children Treated with Anti-TNF-α Agents
by: Aykut EŞKİ, et al.
Published: (2023-07-01)

Nailfold Videocapillaroscopy in Patients with Rheumatoid Arthritis and Psoriatic Arthropathy on ANTI-TNF-ALPHA Therapy
by: Daniela Anghel, et al.
Published: (2023-06-01)

Neuropathie périphérique sous Infliximab: étude d'une observation
by: Ali Zinebi, et al.
Published: (2016-07-01)

Abordagem diagnóstica da tuberculose latente na artrite reumatóide Latent tuberculosis diagnosis in rheumatoid arthritis
by: Cláudia Diniz Lopes Marques, et al.
Published: (2007-12-01)

Latent tuberculosis infection in patients with rheumatic diseases
by: Camila Anton, et al.
Published: (2019-04-01)

Assessing the risk of rapid radiographic progression in Hungarian rheumatoid arthritis patients
by: Edit Végh, et al.
Published: (2021-04-01)

Immunologic Parameters for Disease Activity in Rheumatoid Arthritis
by: E Riyadh Mohsen, et al.
Published: (2021-10-01)

Management of severe hidradenitis suppurativa with biologic therapy and wide excision
by: Shi Yu Derek Lim, et al.
Published: (2019-05-01)

Subcutaneously-Administered Infliximab in the Management of Rheumatoid Arthritis: A Short Narrative Review of Current Clinical Evidence
by: Iannone F, et al.
Published: (2022-06-01)

Pregnancy Outcumes and Contraceptive Use in Women with Rheumatoid Arthritis: A Comparative Study
by: Lobaba Basim Mohammed Salih, et al.
Published: (2022-12-01)

Oleuropein as An Effective Suppressor of Inflammation and MicroRNA-146a Expression in Patients with Rheumatoid Arthritis
by: Hanieh Mahi, et al.
Published: (2023-07-01)

Disseminated tuberculosis infection and paradoxical reaction during antimycobacterial treatment related to TNF-alpha blocker agent Infliximab
by: Mehmet Unlu, et al.
Published: (2014-01-01)

Short-Term Response to Infliximab in Rheumatoid Pattern Polyarthropathy Complicating Ulcerative Colitis
by: ilke Coskun Benlidayi, et al.
Published: (2015-12-01)

ROLE OF TUMOR NECROSIS FACTOR ALPHA IN IMMUNE PATHOGENESIS OF DIFFERENT DISEASES AND ITS SIGNIFICANCE FOR EVOLVING ANTICYTOKINE THERAPY WITH MONOCLONAL ANTIBODIES
by: E. V. Voronina, et al.
Published: (2018-12-01)

INFLIXIMAB (REMICADE): POSSIBILITIES IN THE TREATMENT OF RHEUMATOID ARTHRITIS
by: Nataliya Vladimirovna Chichasova, et al.
Published: (2011-03-01)

Efficacy and safety of levilimab in combination with methotrexate in subjects with rheumatoid arthritis: Results of phase II AURORA study
by: V. I. Mazurov, et al.
Published: (2021-05-01)

Correlation of melatonin and TNF-α levels with characteristics of sleep in patients with rheumatoid arthritis
by: Yu. K. Sikalo, et al.
Published: (2015-02-01)

Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review
by: Jean-Luc Davignon, et al.
Published: (2018-10-01)

Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy
by: Tomasz Wysocki, et al.
Published: (2022-02-01)

New insights into the impact of neuro-inflammation in rheumatoid arthritis
by: Nicholas Rubek Fuggle, et al.
Published: (2014-11-01)

Nephritis, cerebritis, and myositis after adalimumab therapy in a patient with rheumatoid arthritis: a case report
by: Omran NE, et al.
Published: (2018-04-01)

What Is the Clinical Relevance of TNF Inhibitor Immunogenicity in the Management of Patients With Rheumatoid Arthritis?
by: Puja Mehta, et al.
Published: (2020-04-01)

Infliximab in the therapy of rheumatoid arthritis
by: G. V. Lukina, et al.
Published: (2016-05-01)

Tuberculosis in the era of anti-TNF-alpha therapy: Why does the risk still exist?
by: John-Leonardo Torres-Castiblanco, et al.
Published: (2018-03-01)

When Autoantibodies Are Missing: The Challenge of Seronegative Rheumatoid Arthritis
by: Marino Paroli, et al.
Published: (2023-10-01)

Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
by: van der Maas Aatke, et al.
Published: (2012-09-01)

Low Percentage of Signal Regulatory Protein α/β+ Memory B Cells in Blood Predicts Development of Anti-drug Antibodies (ADA) in Adalimumab-Treated Rheumatoid Arthritis Patients
by: Laura Magill, et al.
Published: (2018-12-01)

Comparison of serum tumor necrosis factor-α levels in rheumatoid arthritis individuals with and without chronic periodontitis: A biochemical study
by: Sivasankari Thilagar, et al.
Published: (2018-01-01)

Efficacy and safety of levilimab in combination with methotrexate in patients with active rheumatoid arthritis: 56-week results of phase III randomized double-blind placebo-controlled trial SOLAR
by: V. I. Mazurov, et al.
Published: (2023-03-01)

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
by: M. Rossini, et al.
Published: (2015-03-01)

EFFICACY OF INFLIXIMAB IN THERAPY OF REFRACTORY JUVENILE RHEUMATOID ARTHRITIS (JRA)EFFICACY OF INFLIXIMAB IN THERAPY OF REFRACTORY JUVENILE RHEUMATOID ARTHRITIS (JRA)
by: E.I. Alexeeva, et al.
Published: (2006-01-01)

Hepatorenal pathologies in TNF-transgenic mouse model of rheumatoid arthritis are alleviated by anti-TNF treatment
by: Xuefei Li, et al.
Published: (2023-10-01)

Anti-drug antibodies and rheumatoid factor level in patients with rheumatoid arthritis using the infliximab biosimilar CT-P13
by: Hideo Sakane, et al.
Published: (2022-12-01)

Novel Bispecific Antibody for Synovial-Specific Target Delivery of Anti-TNF Therapy in Rheumatoid Arthritis
by: Mathieu Ferrari, et al.
Published: (2021-02-01)

Targeting Extracellular Vesicles to the Arthritic Joint Using a Damaged Cartilage-Specific Antibody
by: Louise M. Topping, et al.
Published: (2020-02-01)

Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis
by: George W. Reed, et al.
Published: (2019-11-01)

Ülseratif Koliti Komplike Eden Romatoid Paternli Poliartropatide Kısa Dönem Infliximab Yanıtı
by: İlke BENLİDAYI, et al.
Published: (2015-10-01)